Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Selinger

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 1996
Determination of remifentanil, an ultra-short-acting opioid anesthetic, in rat blood by high performance liquid chromatography with ultraviolet detectionS H Haidar, Z Liang, K Selinger, et al.
The Biochemical Journal|June 1, 1975
Hydrodynamic changes accompanying the loss of metal ions from concanavalin AH W Sawyer, R Dabscheck, P R Nott, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1994
Analysis of enloplatin by liquid chromatography and of platinum by atomic absorption spectrometry in various biological fluidsP Amorusi, D Lessard, S K Bansal, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separationJ Bender, J van den Elshout, K Selinger, et al.
Pharmacotherapy|March 1, 1997
Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosisK M Jones, E Liao, K Hohneker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusionJ P Stevenson, D DeMaria, J Sludden, et al.
British Journal of Cancer|March 1, 1996
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administrationC J Gerrits, G J Creemers, J H Schellens, et al.
Investigational New Drugs|May 11, 2002
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesJ H M Schellens, B Heinrich, M Lehnert, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 1996
Determination of remifentanil, an ultra-short-acting opioid anesthetic, in rat blood by high performance liquid chromatography with ultraviolet detectionS H Haidar, Z Liang, K Selinger, et al.
The Biochemical Journal|June 1, 1975
Hydrodynamic changes accompanying the loss of metal ions from concanavalin AH W Sawyer, R Dabscheck, P R Nott, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1994
Analysis of enloplatin by liquid chromatography and of platinum by atomic absorption spectrometry in various biological fluidsP Amorusi, D Lessard, S K Bansal, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 4, 2000
Determination of remifentanil in human heparinised whole blood by tandem mass spectrometry with short-column separationJ Bender, J van den Elshout, K Selinger, et al.
Pharmacotherapy|March 1, 1997
Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosisK M Jones, E Liao, K Hohneker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusionJ P Stevenson, D DeMaria, J Sludden, et al.
British Journal of Cancer|March 1, 1996
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administrationC J Gerrits, G J Creemers, J H Schellens, et al.
Investigational New Drugs|May 11, 2002
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesJ H M Schellens, B Heinrich, M Lehnert, et al.
Pageof 2